Mayne Pharma 2023 Half Year Results Media Release
Mayne Pharma’s CEO, Mr Shawn O'Brien said, “The performance of our business during the first half of FY23 is categorized by building momentum in our Branded Products Division."
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Mayne Pharma Group Limited. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Mayne Pharma Group Limited a question about this update.